Johnson Controls International (JCI) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
8 Jun, 2026Executive summary
Fiscal 2025 delivered 6% organic sales growth, adjusted EPS up 17% to $3.76, and a record ~$15B backlog, with strong free cash flow conversion at 102%.
Operational focus, proprietary business systems, and process improvements drove productivity, customer engagement, and margin expansion.
Orders grew 7% for the year, with Americas strength offsetting APAC softness; backlog up 13% year-over-year.
Strategic investments in technology, sustainability, and leadership, including data center cooling and decarbonization, position the company for long-term growth.
Sale of Residential and Light Commercial HVAC business to Bosch for $8.3B, with $6.9B attributable to the company.
Financial highlights
FY25 organic revenue up 6% year-over-year; Q4 organic revenue up 4%.
Adjusted Segment EBITA margin expanded 100 bps to 17.1% for the year; Q4 margin at 18.8%.
Adjusted EPS for FY25 was $3.76, up 17% year-over-year; Q4 adjusted EPS was $1.26, up 14%.
Adjusted free cash flow for the year was $2.5B, with 102% conversion.
Q4 sales were $6.44B, up 3% year-over-year; gross margin at 36.7%.
Outlook and guidance
FY26 guidance: mid-single-digit organic sales growth, adjusted EPS of ~$4.55 (over 20% growth), operating leverage ~50%, and free cash flow conversion ~100%.
Q1 FY26: organic sales growth ~3%, operating leverage ~55%, adjusted EPS ~$0.83.
Corporate expense for FY26 projected at $375M–$400M; tax rate ~17%.
Long-term targets: mid-single-digit revenue growth, 30%+ operating leverage, double-digit adjusted EPS growth, and ~100% free cash flow conversion.
Latest events from Johnson Controls International
- Q3 delivered growth, margin expansion, record backlog, and major divestitures amid portfolio shift.JCI
Q3 20248 Jun 2026 - Q4 organic sales up 10%, margin expansion, record backlog, and strong FY25 outlook.JCI
Q4 20248 Jun 2026 - Q1 2025 saw 10% organic growth, 39% EPS gain, and raised full-year guidance.JCI
Q1 20258 Jun 2026 - Q2 2025 saw 7% organic sales growth, margin expansion, and raised FY25 guidance.JCI
Q2 20258 Jun 2026 - Q3 saw 6% organic sales growth, record backlog, and expanded share repurchase authorization.JCI
Q3 20258 Jun 2026 - Sales, EPS, and backlog hit records, with raised FY26 guidance and strong demand across regions.JCI
Q1 20268 Jun 2026 - Q2 saw 8% sales growth, 45% adjusted EPS growth, and record backlog, prompting raised guidance.JCI
Q2 20268 Jun 2026 - Innovation and operational excellence drive high single-digit organic growth and service expansion.JCI
Analyst Day 20265 Jun 2026 - Strong order growth, margin gains, and strategic focus drive optimism for future performance.JCI
19th Annual Global Transportation & Industrials Conference20 May 2026